종목

시노백 바이오테크 SVA

헬스케어 섹터나스닥

기업 정보

거래소
나스닥
본사
Beijing
결산일
12/31

5% 지분

보고자
1Globe Capital01/3032.3%18,515,315주+0.0%p
Saif Partners IV01/3015%10,780,820주+0.0%p
Yin Weidong25/07/158.85%6,359,500주+0.0%p
Advantech Capital25/07/148.14%5,851,423주+0.0%p
Saif Partners IV25/07/1415%10,780,820주+0.0%p
Vivo Capital VIII25/07/116.3%4,541,764주+0.0%p
1Globe Capital25/07/0732.3%18,515,315주+0.0%p
1Globe Capital25/07/0332.3%18,515,315주+0.0%p
1Globe Capital25/07/0132.3%18,515,315주직전 보고 없음
Yin Weidong25/06/208.85%6,359,500주+0.0%p
Saif Partners IV25/06/1715%10,780,820주+0.0%p
Vivo Capital VIII25/06/136.3%4,541,764주+0.0%p
Saif Partners IV25/05/2315%10,780,820주+0.0%p
Yin Weidong25/04/308.85%6,359,500주+0.0%p
Saif Partners IV25/04/2915%10,780,820주+0.0%p
Vivo Capital VIII25/04/246.3%4,539,456주직전 보고 없음
Advantech Capital25/04/108.14%5,851,423주+0.0%p
Advantech Capital25/03/258.14%5,851,423주처음 보고
Yin Weidong25/03/218.85%6,359,500주직전 보고 없음
Vivo Capital IX25/03/196.3%4,539,456주직전 보고 없음
시노백 바이오테크 5% 지분 보고 모두 보기

26주 거래 추이